Interest Expense in USD of ARROWHEAD PHARMACEUTICALS, INC. from 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly/annual Interest Expense history and change rate from 2021 to Q1 2024.
  • ARROWHEAD PHARMACEUTICALS, INC. Interest Expense for the quarter ending 31 Mar 2024 was $7.24M, a 43.2% increase year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. Interest Expense for the twelve months ending 31 Mar 2024 was $23M.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Interest Expense for 2023 was $18.3M.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Interest Expense for 2022 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $23M $7.24M +$2.19M +43.2% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $20.8M $5.37M +$2.52M +88.4% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2024
Q3 2023 $18.3M $5.26M 01 Jul 2023 30 Sep 2023 10-K 29 Nov 2023
Q2 2023 $5.16M +$5.16M 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $5.06M +$5.06M 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $2.85M 01 Oct 2022 31 Dec 2022 10-Q 06 Feb 2024
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023

ARROWHEAD PHARMACEUTICALS, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.3M +$18.3M 01 Oct 2022 30 Sep 2023 10-K 29 Nov 2023
2022 $0 $0 01 Oct 2021 30 Sep 2022 10-K 29 Nov 2023
2021 $0 01 Oct 2020 30 Sep 2021 10-K 29 Nov 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.